Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

FDA issues warnings in crackdown on baseless cannabis miracle cures

November 2, 2017 Research and Development, Sales and Marketing FDA, cannabidiol, cannabis, pharma

The FDA has issued a warning over cannabis-based therapies which promise the ability to cure cancer, asserting that such treatments …
News
pregnant-2640994_960_720

New test could determine womens’ risk of miscarriage or premature birth

November 2, 2017 Research and Development biotech, drugs, pharma, pharmaceutical, pregnancy

Scientists in the US have reported findings suggesting that certain molecules in the blood are strongly associated with complications during …
News

Novartis reveals the data behind its showdown with Gilead

November 1, 2017 Research and Development CAR-T, Gilead, Kymriah, Novartis, biotech, drugs, pharma, pharmaceutical

Only yesterday it was revealed that Novartis had applied to the FDA in the same indication that Gilead’s treatment is …
News
csm_tk12_17_rupert_sandbrink_kl_fb0c325239

Topas Therapeutics brings in new CMO

November 1, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Topas Therapeutics, biotech, drugs, pharma, pharmaceutical

Topas Therapeutics, a German company focused on developing novel therapeutics to treat immune-mediated and autoimmune diseases, announced that it has …
Appointment
_97604447_kymriah-product-shot-8

CAR-T is bringing true precision to the fight against cancer

November 1, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR T, CAR-T, Gilead, Kymriah, Novartis, Yescarta

Matt Fellows investigates how the first-ever CAR-T therapy approvals in the past months could mean the field of cancer treatment …
Feature
roche

Roche’s Tecentriq approved for funding in UK in bladder cancer

November 1, 2017 Research and Development, Sales and Marketing Roche, biotech, drugs, pharma, pharmaceutical

In a rare spot of good news for Tecentriq (atezolizumab), after a turbulent period, Roche’s drug has been given the …
News

Indivior’s opioid addiction treatment recommended by FDA advisory panel

November 1, 2017 Research and Development, Sales and Marketing FDA, RGP-6000, Trump, US, indivior, opioid crisis, opioids

Another step has been made in the fight back against the ongoing opioid crisis in the US as it emerges …
News

CEO and President implicated as price-fixing probe widens

November 1, 2017 Research and Development, Sales and Marketing Mylan, Teva, biotech, drugs, pharma, pharmaceutical

A group of states, 45 members-strong, has expanded its probe into the generics pharmaceutical industry by expanding its case to …
News
astrazeneca-sign

AstraZeneca asthma therapy tralokinumab flops at Phase 3

November 1, 2017 Research and Development AstraZeneca, MedImmune, asthma, pharma

AstraZeneca and MedImmune, the company’s global biologics research and development arm, have announced new Phase 3 data revealing that tralokinumab …
News
nhs_sign

Cancer death rates 61% higher in poorer areas

November 1, 2017 Medical Communications, Research and Development NHS, biotech, drugs, pharma, pharmaceutical

Figures released by NHS Scotland have revealed that the numbers of deaths from cancer are 67% higher in the poorest …
News
alzheimers_brain

Over-the-counter multinutrient drink could have beneficial impact on Alzheimer’s, new study reveals

October 31, 2017 Manufacturing and Production, Research and Development Alzheimer's, Fortasyn Connect, Souvenaid, dementia

LipiDiDiet, a European project investigating “the impact of nutritional lipids on neuronal and cognitive performance in ageing, Alzheimer’s disease and …
News
amgen_hq

Kirin Holdings to withdraw from 30 year venture with Amgen, sell shares for $780m

October 31, 2017 Manufacturing and Production, Research and Development, Sales and Marketing Amgen, Kirin, joint venture, pharma

Japanese firm Kirin Holdings has announced its intention to withdraw from a joint research collaboration with Amgen, saying it would …
News
janssen_latest_logo_on_sign_closer

Janssen’s Stelara shows improvement in Crohn’s symptoms within one week, new findings reveal

October 30, 2017 Manufacturing and Production, Research and Development Crohn’s disease, Janssen, Stelara, crohn's disease, pharma

Janssen has unveiled new data on Stelara (ustekinumab) in the treatment of patients with moderately to severely active Crohn’s disease …
News
pfizer-building-logo1web

Switching Crohn’s patients to biosimilar Inflectra from Remicade is safe and effective, Pfizer says

October 30, 2017 Research and Development, Sales and Marketing Crohn’s disease, Pfizer, Remicade, crohn's disease, inflectra, pharma

Pfizer has released new data on its Crohn’s disease (CD) treatment Inflectra (infliximab CT-P13) which indicate that switching patients to …
News
online_survey_icon_or_logo

Collaboration in Biopharma

October 27, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Dear Colleague,
Feature
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026